In Depth 30 Jan 2026 Johnson & Johnson’s pipeline strategy: What does 2026 have in store for the big pharma? Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 billion. January 30, 2026 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Jan 2026 How the University of North Carolina at Chapel Hill is enhancing RNAi potency with its new technology Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi potency. January 27, 2026 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2026 Hepatitis B: Are we edging closer to a cure? Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease. January 20, 2026 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Jan 2026 The biggest biotech funding rounds in December 2025 The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in December 2025. January 9, 2026 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Dec 2025 Eight of the biggest immunology and inflammation (I&I) deals in 2025 Discover eight of the biggest immunology and inflammation (I&I) deals in 2025, from early-stage collaborations to late-stage licensing deals. December 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Dec 2025 Keep an eye on these 15 biotech companies in 2026 Some companies have had wins in 2025, while others have major milestones coming up. Here are 15 biotechs to watch as we head into 2026. December 15, 2025 - 21 minutesmins - Multiple Authors Share WhatsApp Twitter Linkedin Email
In Depth 10 Dec 2025 Promising cure for COPD: Is a breakthrough treatment within reach? Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. December 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2025 The biggest biotech funding rounds in November 2025 The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. December 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2025 Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. November 28, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Nov 2025 11 neuroscience biotech companies you should know about Learn more about 11 of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions. November 25, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2025 Six key obesity deals in 2025 Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies. November 21, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email